Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

National Cancer Institute, Naples

2 clinical trials · 2 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by National Cancer Institute, Naples

RECRUITINGPhase 2NCT07213570

STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer

The investigators hypothesize that patients with mCRC RAS-mutant eligible for a second line treatment with good prognostic features, identified as single metastatic site, long...

Sponsor: National Cancer Institute, NaplesEnrolling: 601 location
Colorectal Cancer Metastatic
RECRUITINGPhase 3NCT05255471

MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in...

MITO 35b is designed as randomized, open label, phase III trial that aims to assess the efficacy of olaparib maintenance beyond progression compered to standard platinum-based...

Sponsor: National Cancer Institute, NaplesEnrolling: 2001 location
Ovarian Cancer